Exabone GmbH is a Swiss biotechnology leader strategically based within the fast growing life science cluster of Western Switzerland.

 

Our mission is summarized in our strapline:

The Swiss Bone Architect.

 

The main focus of the company is on the research, development, manufacturing and commercialization of innovative synthetic bone graft substitutes with unique characteristics.

 

Exabone GmbH and its products are certified by BSI, Notified Body Number 0086 and 2797.

 

The company holds BSI certificate n° MD 582166 and operates a Quality Management System which complies with the requirements of ISO 13485: 2016.

 

The company holds BSI certificate for Full Quality Assurance n° CE 582165 under the requirement of Council Directive 93/42/EEC, Annex II, Section 3.2., in respect of: Design, development and manufacture of synthetic bone graft substitutes.

 

The synthetic bone graft substitutes carry the

CE Mark in Class III.